Because few studies have been conducted on YKL-40 as a novel marker for predicting occult CAD in asymptomatic subjects with normal glucose tolerance or diabetes mellitus, our results make a novel contribution to the clinical relevance of YKL-40 in asymptomatic type 2 diabetic patients. The gene discussed is CHI3L1; the disease is diabetes mellitus.